Regular Article

British Journal of Cancer (2000) 83, 1740–1746. doi:10.1054/bjoc.2000.1514 www.bjcancer.com
Published online 5 December 2000

Characterization of DNA-strand breakage induced in V79 cells by F 11782, a catalytic inhibitor of topoisomerases

J-M Barret1, B T Hill1 and P L Olive2

  1. 1Division de Cancérologie, Centre de RecherchePierre Fabre, 17 avenue Jean Moulin, Castres, 81100, France
  2. 2Medical Biophysics Department, British Columbia Cancer Research Centre, Vancouver, V5Z IL3, Canada

Received 31 March 2000; Revised 7 August 2000; Accepted 13 August 2000.

Top

Abstract

DNA damage induced in V79 cells by F 11782, or 2",3"-bis pentafluorophenoxyacetyl-4', 6'-ethylidene-beta-D glucoside of 4'-phosphate- 4'-demethylepipodophyllotoxin 2N-methyl glucamine salt, a novel dual catalytic inhibitor of topoisomerases I and II, was investigated using both alkaline and neutral versions of the comet assay methodology. A comparison was then made of the DNA damage induced by F 11782 with that induced by either etoposide or camptothecin under comparable experimental conditions. The results revealed that F 11782 initially induced less DNA strand breaks that either etoposide or camptothecin and rejoined such breaks more slowly. However, unlike these other drugs, the extent of DNA damage induced by F 11782 increased linearly with time of incubation. F 11782 produced both DNA single- and double-strand breaks without any clear specificity relative to phase of the cell cycle, although proliferating cells were preferentially damaged. The marked time-dependency of induction of DNA strand breaks by F 11782 may serve to explain, at least in part, its major in vivo antitumour activities. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords:

F 11782, catalytic topoisomerase inhibitor, DNA-strand breaks, comet assay

Top

References

  1. Barret J-M, Montaudon D, Etiévant C, Baudouin C, Limouzy A, Cabrol N, Charvéron M, Robert J and Hill BT (1999) DNA damage induction and DNA repair inhibition by F 11782, a novel catalytic dual inhibitor of topoisomerases I and II. Proc Am Assoc Cancer Res 40: 761
  2. Durand RE (1982) Use of Hoechst 33342 for cell selection of multicell systems. J Histochem Cytochem 30: 117–122 | PubMed | ChemPort |
  3. Etiévant C, Kruczynski A, Perrin D, Cabrol N, Cassabois V, Chansard N and Hill BT (1999) In vitro cytotoxic effects of F 11782, a novel catalytic dual inhibitor of topoisomerases I and II. Proc Am Assoc Cancer Res 40: 759
  4. Guminski Y, Cugnasse S, Fabre V, Monse B, Kruczynski A, Etiévant C, Hill BT and Imbert T (1999) Synthesis and antitumor activity of a novel epipodophylloid: F 11782, a dual inhibitor of topoisomerases I and II. Proc Am Assoc Cancer Res 40: 4510
  5. Klaude M, Eriksson S, Nygren J and Ahnström G (1996) The comet assay: mechanisms and technical considerations. Mutat Res 363: 89–96 | PubMed | ChemPort |
  6. Kruczynski A, Astruc J, Chazottes E, Ricome C, Berrichon G, Imbert T, Colpaert F and Hill BT (1999) Preclinical antitumor activity of F 11782, a novel catalytic dual inhibitor of topoisomerases I and II. Proc Am Assoc Cancer Res 40: 757
  7. Ng S-W, Liu Y, Hasselblatt KT, Mok SC and Berkowitz RS (1999) A new human topoisomerase III that interacts with SGS1 protein. Nucleic Acids Res 27: 993–1000 | Article | PubMed | ISI | ChemPort |
  8. Nitiss JL (1998) Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta 1400: 63–81 | Article | PubMed | ISI | ChemPort |
  9. Olive PL and Banáth JP (1993) Induction and rejoining of radiation-induced DNA single-strand breaks: "tail moment" as a function of position in the cell cycle. Mutat Res 294: 275–283
  10. Olive PL, Banáth JP and Durand RE (1990) Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the 'Comet assay'. Radiat Res 122: 86–94 | Article | PubMed | ISI | ChemPort |
  11. Olive PL, Banáth JP and Evans HH (1993) Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging. Br J Cancer 67: 522–530
  12. Olive PL, Banáth JP and Durand RE (1997) Detection of subpopulations resistant to DNA-damaging agents in spheroids and murine tumours. Radiat Res 375: 157–165
  13. Olive PL and Johnston PJ (1997) DNA damage from oxidants: influence of lesion complexity and chromatin organization. Oncol Res 9: 287–294 | PubMed | ISI | ChemPort |
  14. Perrin D, Kruczynski A, Barret J-M, Etiévant C, Chansard N, Gras S, Limouzy A, Rigaud S and Hill BT (1999) Biological characterization of the in vitro activities of F 11782, a novel catalytic dual inhibitor of topoisomerases I and II. Proc Am Assoc Cancer Res 40: 756
  15. Perrin D, Van Hille B, Barret J-M, Kruczynski A, Etiévant C, Imbert T and Hill BT (2000) F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action. Biochem Pharmacol 59: 807–819
  16. Sutherland RM (1988) Cell and environment interactions in tumor microregions: The multicell spheroids model. Science 240: 177–184 | Article | PubMed | ISI | ChemPort |

Extra navigation

naturejobs

  • Faculty Positions

    • Amrita Institute of Medical Sciences
    • Amrita Lane, Elamakkara Post, Kochi, Kerala 682 026,India
  • Postdoctoral Position

    • German Cancer Research Center
    • Heidelberg 69120 Germany

natureproducts